Additional file 1 of CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28245106
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 1 of CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer

Figshare
Cancer Cells and Metastasis
article

Additional file 1 of CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer

article en

Abstract

No abstract available for this paper.
Figshare
University of Milan (IT), Istituti Clinici Scientifici Maugeri (IT), IFOM (IT), IRCCS Ospedale San Raffaele (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Openalex Percentile: Top 39%
Cancer Cells and Metastasis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Additional file 1 of CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer · Figshare (2025) | TGRS Research Map | TGRS